DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
When do Dopamine Hydrochloride In Dextrose 5% patents expire, and when can generic versions of Dopamine Hydrochloride In Dextrose 5% launch?
Dopamine Hydrochloride In Dextrose 5% is a drug marketed by Hospira and Baxter Hlthcare and is included in three NDAs.
The generic ingredient in DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% is dopamine hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dopamine Hydrochloride In Dextrose 5%
A generic version of DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% was approved as dopamine hydrochloride by HOSPIRA on February 4th, 1982.
Summary for DOPAMINE HYDROCHLORIDE IN DEXTROSE 5%
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Clinical Trials: | 996 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% at DailyMed |
Recent Clinical Trials for DOPAMINE HYDROCHLORIDE IN DEXTROSE 5%
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dr. Ulrike Grittner | N/A |
Virginia Commonwealth University | Phase 2 |
Prof. Dr. Soyoung Q Park | N/A |
See all DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% clinical trials